Free Trial
NYSE:MED

Medifast (MED) Stock Price, News & Analysis

Medifast logo
$14.28 +0.71 (+5.22%)
Closing price 08/22/2025 03:59 PM Eastern
Extended Trading
$14.29 +0.01 (+0.08%)
As of 04:04 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Medifast Stock (NYSE:MED)

Key Stats

Today's Range
$13.67
$14.42
50-Day Range
$12.77
$15.22
52-Week Range
$11.57
$21.98
Volume
224,160 shs
Average Volume
197,680 shs
Market Capitalization
$156.92 million
P/E Ratio
44.62
Dividend Yield
N/A
Price Target
$16.50
Consensus Rating
Hold

Company Overview

Medifast Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
73rd Percentile Overall Score

MED MarketRank™: 

Medifast scored higher than 73% of companies evaluated by MarketBeat, and ranked 69th out of 146 stocks in the consumer staples sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Medifast has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 1 hold rating, and no sell ratings.

  • Amount of Analyst Coverage

    Medifast has received no research coverage in the past 90 days.

  • Read more about Medifast's stock forecast and price target.
  • Earnings Growth

    Earnings for Medifast are expected to grow by 200.00% in the coming year, from $0.51 to $1.53 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Medifast is 44.62, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 28.44.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Medifast is 44.62, which means that it is trading at a more expensive P/E ratio than the Consumer Staples sector average P/E ratio of about 18.72.

  • Price to Book Value per Share Ratio

    Medifast has a P/B Ratio of 0.74. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Medifast's valuation and earnings.
  • Percentage of Shares Shorted

    21.87% of the float of Medifast has been sold short.
  • Short Interest Ratio / Days to Cover

    Medifast has a short interest ratio ("days to cover") of 9.8.
  • Change versus previous month

    Short interest in Medifast has recently increased by 2.69%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Medifast does not currently pay a dividend.

  • Dividend Growth

    Medifast does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    21.87% of the float of Medifast has been sold short.
  • Short Interest Ratio / Days to Cover

    Medifast has a short interest ratio ("days to cover") of 9.8.
  • Change versus previous month

    Short interest in Medifast has recently increased by 2.69%, indicating that investor sentiment is decreasing.
  • News Sentiment

    Medifast has a news sentiment score of 0.50. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.90 average news sentiment score of Consumer Staples companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Medifast this week, compared to 3 articles on an average week.
  • Search Interest

    6 people have searched for MED on MarketBeat in the last 30 days. This is an increase of 500% compared to the previous 30 days.
  • MarketBeat Follows

    2 people have added Medifast to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Medifast insiders have bought more of their company's stock than they have sold. Specifically, they have bought $5,003.00 in company stock and sold $0.00 in company stock.

  • Percentage Held by Insiders

    Only 2.90% of the stock of Medifast is held by insiders.

  • Percentage Held by Institutions

    95.51% of the stock of Medifast is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Medifast's insider trading history.
Receive MED Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Medifast and its competitors with MarketBeat's FREE daily newsletter.

MED Stock News Headlines

Why Medifast (MED) Stock Is Trading Up Today
Musk’s Project Colossus could mint millionaires
I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.tc pixel
Medifast (MED) Stock Trades Up, Here Is Why
Medifast’s Earnings Call: Challenges and Optimism
See More Headlines

MED Stock Analysis - Frequently Asked Questions

Medifast's stock was trading at $17.62 at the beginning of 2025. Since then, MED stock has decreased by 19.0% and is now trading at $14.2780.

Medifast Inc (NYSE:MED) issued its quarterly earnings results on Monday, August, 4th. The specialty retailer reported $0.04 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.22) by $0.26. The specialty retailer had revenue of $105.56 million for the quarter, compared to analysts' expectations of $96.10 million. Medifast had a net margin of 0.76% and a trailing twelve-month return on equity of 2.00%.
Read the conference call transcript
.

Medifast's top institutional investors include Acadian Asset Management LLC (3.74%), Bank of America Corp DE (3.61%), Geode Capital Management LLC (2.31%) and American Century Companies Inc. (1.95%). Insiders that own company stock include Daniel R Chard, Scott Schlackman, Andrea B Thomas, Jeffrey J Brown and Constance J Hallquist.
View institutional ownership trends
.

Shares of MED stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Medifast investors own include American Water Works (AWK), Waste Connections (WCN), Humana (HUM), The RMR Group (RMR), DiamondRock Hospitality (DRH), Voyager Therapeutics (VYGR) and AU Optronics (AUOTY).

Company Calendar

Last Earnings
8/04/2025
Today
8/24/2025
Next Earnings (Estimated)
11/03/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Industry
FOOD - MISC/DIVERSIFIED
Sub-Industry
Personal Products
Current Symbol
NYSE:MED
CIK
910329
Employees
870
Year Founded
1981

Price Target and Rating

High Price Target
$16.50
Low Price Target
$16.50
Potential Upside/Downside
+15.6%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
1 Analysts

Profitability

EPS (Trailing Twelve Months)
$0.32
Trailing P/E Ratio
44.62
Forward P/E Ratio
28.00
P/E Growth
N/A
Net Income
$2.09 million
Net Margins
0.76%
Pretax Margin
1.30%
Return on Equity
2.00%
Return on Assets
1.50%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
4.47
Quick Ratio
3.82

Sales & Book Value

Annual Sales
$602.46 million
Price / Sales
0.26
Cash Flow
$2.93 per share
Price / Cash Flow
4.87
Book Value
$19.21 per share
Price / Book
0.74

Miscellaneous

Outstanding Shares
10,990,000
Free Float
10,672,000
Market Cap
$156.92 million
Optionable
Optionable
Beta
0.80

Social Links

7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

This page (NYSE:MED) was last updated on 8/25/2025 by MarketBeat.com Staff
From Our Partners